17/03/08 - St George's Hospital Trial Judgement
17/03/08 - St George's Hospital Trial Judgement
17/03/08 - St George's Hospital Trial Judgement
The Board of Daval International Limited decided, in 2004, to terminate the first full-scale clinical trial of AIMSPRO at St George's Hospital, London. The Company had drawn on a broad range of Medical and Pharmaceutical opinion to form this important decision, which was necessitated by the sub-standard handling of trial medication at the hospital's pharmacy, with the possible risk to patient safety and data integrity. A complaint against the responsible hospital pharmacist was then lodged by Daval with the Royal Pharmaceutical Society of Great Britain.
The allegations of misconduct against the pharmacist were considered by the Investigating Committee on 4th March 2008 and it's judgement fully vindicates Daval's action in discontinuing this study, which was a two year placebo-controlled, double blind study of AIMSPRO as a potential palliative medication for Secondary Progressive Multiple Sclerosis.
The Committee reasoned that there were a number of factors and areas of responsibility which contributed to the failure of the clinical trial and that the pharmacist had failed to take control of his responsibilities by ensuring that appropriate standard operating procedures were in place.
Although this matter has taken some time to be resolved, Daval is pleased that the accusations which have been circulated by malicious and irresponsible parties since 2004, regarding the Company's motives in terminating the trial, have been satisfactorily quashed. As regards future human studies, Daval's interests are somewhat protected by the tighter Clinical Trial regulations in the United States, Europe and Australia that are now in force. It is re-stated that the company's over-riding priority, as it passes through the development phase of AIMSPRO, a complex biological medication, will be that of patient safety.
Daval adheres to the Code of Practice of the ABPI, of which it is a member.
Daval International Limited
17 March 2008
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 719 Views
-
Last post by NHE
Thu Aug 30, 2018 10:00 pm
-
- 1 Replies
- 165 Views
-
Last post by Jaded
Tue Feb 26, 2019 12:31 pm
-
- 1 Replies
- 215 Views
-
Last post by Zyklon
Tue Aug 13, 2019 8:56 am
-
-
Simvastatin trial for SPMS in UK recruiting
by frodo » Fri Mar 15, 2019 4:42 am » in General Discussion - 1 Replies
- 219 Views
-
Last post by Jaded
Wed Mar 20, 2019 9:36 am
-
-
- 2 Replies
- 612 Views
-
Last post by ElliotB
Sat Sep 29, 2018 3:08 am
-
-
Cerebral blood-flow clinical trial
by frodo » Fri May 10, 2019 7:45 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 2 Replies
- 417 Views
-
Last post by NHE
Wed May 22, 2019 3:24 am
-
-
-
Progressive (and RR) trial seeking participants - EBV based
by CureOrBust » Mon May 28, 2018 1:10 am » in Drug Pipeline - 0 Replies
- 1486 Views
-
Last post by CureOrBust
Mon May 28, 2018 1:10 am
-
-
-
Anti EBV Trial Shows Promise in Progressive MS
by seeva » Fri Nov 23, 2018 3:03 am » in Drug Pipeline - 0 Replies
- 1283 Views
-
Last post by seeva
Fri Nov 23, 2018 3:03 am
-
-
-
Zamboni: Review of the Brave Dreams trial
by frodo » Sat Jul 28, 2018 10:45 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 988 Views
-
Last post by frodo
Sat Jul 28, 2018 10:45 am
-